Insider Trading - Pontifax Late Stage GP Ltd.

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Pontifax Late Stage GP Ltd.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-11-11
Purchase
2019-11-13
7:10 pm
89bio Inc. ETNB Kariv Tomer
Pontifax (Israel) V L.P.
Pontifax (Cayman) V L.P.
Pontifax (China) V L.P.
Pontifax 5 G.P. L.P.
Pontifax Management 4 G.P. (2015) Ltd.
Pontifax Late Stage GP Ltd.
Pontifax Late Stage Fund L.P.
Director
10% Owner
250,000 $16 $4,000,000 1,134,671
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:18 pm
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
437,499 $16 $6,999,984 149,262
(Indirect)
View
2020-11-17
Purchase
2020-11-19
4:38 pm
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
60,000 $50 $3,000,000 155,262
(Indirect)
View
2020-11-17
Purchase
2020-11-19
4:39 pm
Keros Therapeutics Inc. KROS Kariv Tomer
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner
60,000 $50 $3,000,000 155,262
(Indirect)
View
2020-11-17
Purchase
2020-11-19
4:40 pm
Keros Therapeutics Inc. KROS Nussbaum Ran
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner
60,000 $50 $3,000,000 155,262
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-11-11
Conversion
2019-11-13
7:10 pm
N/A
N/A
89bio Inc. ETNB Kariv Tomer
Pontifax (Israel) V L.P.
Pontifax (Cayman) V L.P.
Pontifax (China) V L.P.
Pontifax 5 G.P. L.P.
Pontifax Management 4 G.P. (2015) Ltd.
Pontifax Late Stage GP Ltd.
Pontifax Late Stage Fund L.P.
Director
10% Owner
6,384,672 $0 1,134,671
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
3,545,100 $0 149,262
(Indirect)
View